Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Not Yet Recruiting

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

NCT07407660

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage

NCT06991920

Conditions: Adult ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia

NCT07386392

Conditions: Acute Myeloid Leukemia, Anxiety Disorders, Hematologic Diseases, +7 more
Locations: IUCT Oncopole Toulouse, France

View Trial Details

Not Yet Recruiting

Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)

NCT07371533

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia

NCT07370064

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The Affiliated Hospital oh Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

NCT07355335

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, KMT2A-rearranged, +6 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world

NCT07356960

Conditions: Acute Lymphobkastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

NCT07185490

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .

NCT07343687

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT07342244

Conditions: AML, AML (Acute Myeloid Leukemia), Hematologic Diseases, +6 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Leukemia

Leukemia trial results

Related conditions